Bachem Holding AGCHIX:BANBZ +0.90%93 OCF Margin % is 48.57% as of Dec. 2025, which is 144% above its 10-year median of 19.94. GuruFocus rates CHIX:BANBZ with a GF Score™ of 93/100 and a GF Value™ of CHF97.05 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Bachem Holding AG ranks better than 92.49% on this metric.
The historical rank and industry rank for Bachem Holding AG's OCF Margin % or its related term are showing as below:
CHIX:BANBz'
s OCF Margin % Range Over the Past 10 Years
Min: 9.12 Med: 19.94 Max: 43.28
Current: 39.07
During the past 13 years, the highest OCF Margin % of Bachem Holding AG was 43.28%. The lowest was 9.12%. And the median was 19.94%.
CHIX:BANBz's OCF Margin % is ranked better than 92.49% of 959
companies
in the Biotechnology industry
Industry Median: -66.52
vs CHIX:BANBz: 39.07
Bachem Holding AG OCF Margin % Related Terms
Bachem Holding AG OCF Margin % Historical Data
* Premium members only.
The historical data trend for Bachem Holding AG's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BANBZ vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, Bachem Holding AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bachem Holding AG OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bachem Holding AG's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Bachem Holding AG's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bachem Holding AG (CHIX:BANBZ) has a OCF Margin % of 48.57% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bachem Holding AG and its competitors. This is 144% above median its historical median of 19.94. Over the past decade, Bachem Holding AG's OCF Margin % has ranged from 9.12 to 43.28. According to the industry distribution chart, Bachem Holding AG ranks #72 out of 959 companies in the Biotechnology industry, placing it in the top 7.5%.
Is Bachem Holding AG's OCF Margin % too high?
Bachem Holding AG's current OCF Margin % of 48.57% is 144% above median its 10-year median of 19.94. Over the past 10 years, this metric has ranged from a low of 9.12 to a high of 43.28. Based on the distribution chart, Bachem Holding AG ranks #72 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bachem Holding AG has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #72 out of 959 companies for OCF Margin %. This places Bachem Holding AG in the top 8% of its industry — outperforming the majority of peers. Historically, Bachem Holding AG's own OCF Margin % has ranged from 9.12 to 43.28 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bachem Holding AG and its competitors. Bachem Holding AG's current OCF Margin % is 48.57%, which is 144% above median its own 10-year median of 19.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (CHIX:BANBZ) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF97.05, compared to a current price of CHF67.50 — trading 30.4% below its estimated fair value. The current OCF Margin % is 48.57%, which is 144% above median its 10-year median of 19.94. Bachem Holding AG's overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bachem Holding AG (CHIX:BANBZ), the current OCF Margin % is 48.57% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bachem Holding AG (CHIX:BANBZ) Overvalued in 2026?
Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued.
The current stock price of CHF67.50 is trading 30.4% below its estimated GF Value™ of CHF97.05.
GuruFocus considers Bachem Holding AG to be Significantly Undervalued.
Key valuation signals for CHIX:BANBZ:
OCF Margin %: 48.57% (144% above median its 10-year median of 19.94)
GF Value™: CHF97.05 vs. price of CHF67.50 (30.4% below fair value)
No single metric tells the full story. See the CHIX:BANBZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
93GF Score
Get the complete analysis for CHIX:BANBZ
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BANBZ has been successfully added to your 
